[1] Leva GD, Garofalo M, Croce CM. MicroRNAs in cancer[J]. Annu Rev Pathol, 2014, 9: 287-314.
[2] Wang JY, Chen LJ. The role of microRNAs in the invasion and metastasis of cervical cancer[J]. Biosci Rep, 2019, 39(3): BSR20181377.
[3] Sun YD, Zhou J, Zhao ZhQ, et al. Advances in the study of microRNA-27a in regulating vascular system diseases [J].Chinese Journal of Vascular Surgery (Electronic Edition), 2018,10(2): 150-153, 160.(in Chinese)
孙羽东,周建,赵志青,等. miR-27a参与调控血管系统疾病研究进展[J].中国血管外科杂志(电子版),2018,10(2):150-153, 160.
[4] Bray F, Ferlay J, Soerjomataram Ⅰ, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[5] Farh KK, Grimson A, Jan C, et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution[J].Science, 2005, 310(5755):1817-1821.
[6] Ji W, Sun B, Su C. Targeting microRNAs in cancer gene therapy[J]. Genes (Basel), 2017, 8(1): 21.
[7] Li ChF, Jing W, Xiang DSh, et al. Expression of microRNA-613 in human glioma and its effect on proliferation and metastasis [J].Acta Anatomica Sinica, 2018,49 (5):579-583. (in Chinese)
李传芬,荆文,向冬生,等.MicroRNA-613在人胶质瘤中的表达及其对增殖与转移的影响[J].解剖学报,2018,49(5):579-583.
[8] Zhang Y, Yang Y, Liu R, et al. Downregulation of microRNA-425-5p suppresses cervical cancer tumorigenesis by targeting AIFM1[J]. Exp Ther Med, 2019, 17(5):4032-4038.
[9] Wang L, Wang W, Wu Y. MicroRNA-26b acts as an antioncogene and prognostic factor in cervical cancer[J]. Oncol Lett, 2019, 17(3):3418-3424.
[10] Kong Q, Tang Z, Xiang F, et al. Diagnostic value of serum hsa-mir-92a in patients with cervical cancer[J]. Clin Lab, 2017, 63(2): 335-340.
[11] Zhang LY, Chen Y, Jia J, et al. MiR-27a promotes EMT in ovarian cancer through active Wnt/β-catenin signalling by targeting FOXO1[J]. Cancer Biomark, 2019, 24(1):31-42.
[12] Gao W, Hong Z, Huang H,et al. miR-27a in serum acts as biomarker for prostate cancer detection and promotes cell proliferation by targeting Sprouty2[J]. Oncol Lett, 2018, 16(4):5291-5298.
[13] Ba S, Xuan Y, Long ZW,et al. MicroRNA-27a promotes the proliferation and invasiveness of colon cancer cells by targeting SFRP1 through the Wnt/β-catenin signaling pathway[J]. Cell Physiol Biochem, 2017, 42(5):1920-1933.
[14] Wu F, Li J, Guo N, et al. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway[J]. Am J Cancer Res, 2017, 7(3):405-416.
[15] Chen S, Sun YY, Zhang ZX, et al. Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway[J]. Oncotarget, 2017, 8(9):14708-14718.
[16] Lin T, Ma Q, Zhang Y, et al. MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1[J]. Oncol Lett, 2018, 15(1):1067-1071.
[17] Gocze K, Gombos K, Juhasz K, et al. Unique microRNA expression profiles in cervical cancer[J]. Anticancer Res, 2013, 33(6):2561-2567.
[18] Gocze K, Gombos K, Kovacs K, et al. MicroRNA expressions in HPV-induced cervical dysplasia and cancer[J]. Anticancer Res, 2015, 35(1):523-530.
[19] Jiang G, Shi W, Fang H,et al. miR 27a promotes human breast cancer cell migration by inducing EMT in a FBXW7 dependent manner[J]. Mol Med Rep, 2018, 18(6):5417-5426.
[20] Liu Z, Liu X, Liu S,et al. Cholesterol promotes the migration and invasion of renal carcinoma cells by regulating the KLF5/miR-27a/FBXW7 pathway[J]. Biochem Biophys Res Commun,2018, 502(1):69-75.
[21] Wu XZ, Wang KP, Song HJ, et al. MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression[J]. Int J Clin Exp Med, 2015, 8(9):15556-15562.
[22] Yeh CH, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers[J]. Mol Cancer, 2018, 17(1):115.
[23] Xu Y, Yu J, Liu T,et al. Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma[J]. Biomarkers, 2016, 21(4):379-385.
[24] Zhou C, Shen L, Mao L, et al. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7[J]. Biochem Biophys Res Commun, 2015, 458(1):63-69.
|